A Novel Zero-Retention Suturing Technique in Labiaplasty: Eliminating Suture-Related Complications and Optimizing Aesthetic Outcomes.

Abstract

Background: Most of the labiaplasty suturing methods do not involve the removal of subcutaneous tissue sutures, which are associated with suture-related adverse events. A novel labiaplasty suturing technique was presented to avoid suture-related adverse events and to improve surgery efficiency.

Methods: Between September 2019 and April 2021, labiaplasty for 68 patients were performed using this new suturing technique. All sutures were removed 7 days postoperatively and all patients were followed-up and evaluated three months postoperatively.

Results: Overall, 127 labiaplasties were performed using the new suturing technique. The mean operation times were 42.2 ± 12.6 min (range: 30-60 min) for bilateral labiaplasty (59 cases) and 26.7 ± 8.3 min (20-40 min) for unilateral labiaplasty (nine cases). At the postoperative follow-up evaluations, the incisions had healed well without suture-related adverse effects, marginal scarring was inconspicuous, and no notches were detected at the edge of incision. Sixty-two patients (91.2%) had a score of ≥ 21 points on the female genital self-image scale. Five patients experienced some bleeding (mild bleeding in the early postoperative period, oozing blood from the incision, which can be stopped by applying local pressure) at the edge of incision within 72 h postoperatively, which improved after moderate compression treatment. One patient experienced unilateral, epithelial loss (approx. 3 mm², full thickness) of the labia minora five days postoperatively; this healed 20 days post-operatively. Three patients complained of mild pain (visual analogue scale score: 1-2) on suture removal.

Conclusions: We introduced a novel, safe, simple, and clinically feasible suturing technique for labiaplasty. This new method effectively helps to avoid suture-related adverse effects and obtain a well-shaped edge for the labia minora.

Level of evidence iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .